HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The novel and systemically active metabotropic glutamate 1 (mGlu1) receptor antagonist 3-MATIDA reduces post-ischemic neuronal death.

Abstract
We examined the pharmacological properties of 3-methyl-aminothiophene dicarboxylic acid (3-MATIDA) by measuring second messenger responses in baby hamster kidney cells stably transfected with mGlu1a, mGlu2, mGlu4a or mGlu5a receptors and ionotropic glutamate receptor agonist-induced depolarizations in mouse cortical wedges. 3-MATIDA was a potent (IC(50)=6.3 microM, 95% confidence limits 3-15) and relatively selective mGlu1 receptor antagonist. When tested on mGlu2, mGlu4 or mGlu5 receptors its IC(50) was >300 microM. When tested in cortical wedges, however, 3-MATIDA was also able to antagonize AMPA or NMDA responses with an IC(50) of 250 microM. When present in the incubation medium of cultured murine cortical cells, 3-MATIDA (1-100 microM) significantly reduced the death of neurons induced by 60 min of oxygen and glucose deprivation (OGD), even when added up to 60 min after OGD. A similar neuroprotective activity was observed when 3-MATIDA was present at 10-100 microM in the medium of rat organotypic hippocampal slice cultures exposed to 30 min OGD. Systemic administration of 3-MATIDA (3-10 mg/kg, immediately and 1 h after the onset of ischemia) reduced the volume of brain infarcts following permanent middle cerebral artery occlusion in rats. Our results show that 3-MATIDA is a potent and possibly selective mGlu 1 receptor antagonist that may be considered as a novel prototype neuroprotective agent.
AuthorsFlavio Moroni, Sabina Attucci, Andrea Cozzi, Elena Meli, Roberta Picca, Mark A Scheideler, Roberto Pellicciari, Christian Noe, Iran Sarichelou, Domenico E Pellegrini-Giampietro
JournalNeuropharmacology (Neuropharmacology) Vol. 42 Issue 6 Pg. 741-51 (May 2002) ISSN: 0028-3908 [Print] England
PMID12015200 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • 3-methyl-aminothiophene dicarboxylic acid
  • Excitatory Amino Acid Antagonists
  • Receptors, Metabotropic Glutamate
  • Thiophenes
  • metabotropic glutamate receptor type 1
Topics
  • Animals
  • Brain Ischemia (drug therapy, pathology)
  • Cell Death (drug effects)
  • Cell Hypoxia (drug effects, physiology)
  • Cells, Cultured
  • Cricetinae
  • Dose-Response Relationship, Drug
  • Excitatory Amino Acid Antagonists (chemistry, pharmacology, therapeutic use)
  • Hippocampus (drug effects, pathology)
  • Infarction, Middle Cerebral Artery (drug therapy, pathology)
  • Mice
  • Neurons (drug effects, pathology)
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Metabotropic Glutamate (antagonists & inhibitors, physiology)
  • Thiophenes (chemistry, pharmacology, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: